231 research outputs found
Discovery by a proteomic approach of possible early biomarkers of drug-induced nephrotoxicity in medication-overuse headache
BACKGROUND:
Medication-overuse headache (MOH) is a chronic headache condition that results from the overuse of analgesics drugs, triptans, or other antimigraine compounds. The epidemiology of drug-induced disorders suggests that medication overuse could lead to nephrotoxicity, particularly in chronic patients. The aim of this work was to confirm and extend the results obtained from a previous study, in which we analyzed the urinary proteome of 3 MOH patients groups: non-steroidal anti-inflammatory drugs (NSAIDs), triptans and mixtures abusers, in comparison with non-abusers individuals (controls).
METHODS:
In the present work we employed specialized proteomic techniques, namely two-dimensional gel electrophoresis (2-DE) coupled with mass spectrometry (MS), and the innovative Surface-Enhanced Laser Desorption/Ionization Time-of-Flight mass spectrometry (SELDI-TOF-MS), to discover characteristic proteomic profiles associated with MOH condition.
RESULTS:
By 2-DE and MS analysis we identified 21 over-excreted proteins in MOH patients, particularly in NSAIDs abusers, and the majority of these proteins were involved in a variety of renal impairments, as resulted from a literature search. Urine protein profiles generated by SELDI-TOF-MS analysis showed different spectra among groups. Moreover, significantly higher number of total protein spots and protein peaks were detected in NSAIDs and mixtures abusers.
CONCLUSIONS:
These findings confirm the presence of alterations in proteins excretion in MOH patients. Analysis of urinary proteins by powerful proteomic technologies could lead to the discovery of early candidate biomarkers, that might allow to identify MOH patients prone to develop potential drug overuse-induced nephrotoxicity
Inflammation: an important parameter in the search of prostate cancer biomarkers
Background
A more specific and early diagnostics for prostate cancer (PCa) is highly desirable. In this study, being inflammation the focus of our effort, serum protein profiles were analyzed in order to investigate if this parameter could interfere with the search of discriminating proteins between PCa and benign prostatic hyperplasia (BPH).
Methods
Patients with clinical suspect of PCa and candidates for trans-rectal ultrasound guided prostate biopsy (TRUS) were enrolled. Histological specimens were examined in order to grade and classify the tumor, identify BPH and detect inflammation. Surface Enhanced Laser Desorption/Ionization-Time of Flight-Mass Spectrometry (SELDI-ToF-MS) and two-dimensional gel electrophoresis (2-DE) coupled with Liquid Chromatography-MS/MS (LC-MS/MS) were used to analyze immuno-depleted serum samples from patients with PCa and BPH.
Results
The comparison between PCa (with and without inflammation) and BPH (with and without inflammation) serum samples by SELDI-ToF-MS analysis did not show differences in protein expression, while changes were only observed when the concomitant presence of inflammation was taken into consideration. In fact, when samples with histological sign of inflammation were excluded, 20 significantly different protein peaks were detected. Subsequent comparisons (PCa with inflammation vs PCa without inflammation, and BPH with inflammation vs BPH without inflammation) showed that 16 proteins appeared to be modified in the presence of inflammation, while 4 protein peaks were not modified. With 2-DE analysis, comparing PCa without inflammation vs PCa with inflammation, and BPH without inflammation vs the same condition in the presence of inflammation, were identified 29 and 25 differentially expressed protein spots, respectively. Excluding samples with inflammation the comparison between PCa vs BPH showed 9 unique PCa proteins, 4 of which overlapped with those previously identified in the presence of inflammation, while other 2 were new proteins, not identified in our previous comparisons.
Conclusions
The present study indicates that inflammation might be a confounding parameter during the proteomic research of candidate biomarkers of PCa. These results indicate that some possible biomarker-candidate proteins are strongly influenced by the presence of inflammation, hence only a well-selected protein pattern should be considered for potential marker of PCa
Dynamic thiol/disulphide homeostasis before and after radical prostatectomy in patients with prostate cancer
Thiol groups are important anti-oxidants and essential molecules protecting organism against the harmful effects of reactive oxygen species (ROS). The aim of our study is to evaluate thiol–disulphide homeostasis with a novel recent automated method in patients with localized prostate cancer (PC) before and six months after radical prostatectomy (RP). 18 patients with PC and 17 healthy control subjects were enrolled into the study. Blood samples were collected from the controls subjects and patients before and six months after RP. Thiol–disulphide homeostasis was determined using a recently developed novel method. Prostate-specific antigen (PSA), albumin, total protein, total thiol, native thiol, disulphide and total antioxidant status (TAS) were measured and compared between the groups. Native thiol, total thiol and TAS levels were significantly higher in the control group than the patients before RP (p <.001). There was a non-significant increase in the native thiol, total thiol and TAS levels in the patients six months after RP in comparison to the levels before RP (p values.3,.3 and.09, respectively). We found a significant negative correlation between PSA and thiol levels. Our study demonstrated that the decreased thiol and TAS levels weakened anti-oxidant defence mechanism in the patients with PC as indicated. Increased oxidative stress in prostate cancer patients may cause metabolic disturbance and have a role in the aetiopathogenesis of prostate cancer
Improved Measurement of the Positive Muon Lifetime and Determination of the Fermi Constant
The mean life of the positive muon has been measured to a precision of 11 ppm
using a low-energy, pulsed muon beam stopped in a ferromagnetic target, which
was surrounded by a scintillator detector array. The result, tau_mu =
2.197013(24) us, is in excellent agreement with the previous world average. The
new world average tau_mu = 2.197019(21) us determines the Fermi constant G_F =
1.166371(6) x 10^-5 GeV^-2 (5 ppm). Additionally, the precision measurement of
the positive muon lifetime is needed to determine the nucleon pseudoscalar
coupling g_P.Comment: As published version (PRL, July 2007
An Improved Limit on the Muon Electric Dipole Moment
Three independent searches for an electric dipole moment (EDM) of the
positive and negative muons have been performed, using spin precession data
from the muon g-2 storage ring at Brookhaven National Laboratory. Details on
the experimental apparatus and the three analyses are presented. Since the
individual results on the positive and negative muon, as well as the combined
result, d=-0.1(0.9)E-19 e-cm, are all consistent with zero, we set a new muon
EDM limit, |d| < 1.9E-19 e-cm (95% C.L.). This represents a factor of 5
improvement over the previous best limit on the muon EDM.Comment: 19 pages, 15 figures, 7 table
Measurement of the Negative Muon Anomalous Magnetic Moment to 0.7 ppm
The anomalous magnetic moment of the negative muon has been measured to a
precision of 0.7 parts per million (ppm) at the Brookhaven Alternating Gradient
Synchrotron. This result is based on data collected in 2001, and is over an
order of magnitude more precise than the previous measurement of the negative
muon. The result a_mu= 11 659 214(8)(3) \times 10^{-10} (0.7 ppm), where the
first uncertainty is statistical and the second is sytematic, is consistend
with previous measurements of the anomaly for the positive and negative muon.
The average for the muon anomaly a_{mu}(exp) = 11 659 208(6) \times 10^{-10}
(0.5ppm).Comment: 4 pages, 4 figures, submitted to Physical Review Letters, revised to
reflect referee comments. Text further revised to reflect additional referee
comments and a corrected Fig. 3 replaces the older versio
Polarised Quark Distributions in the Nucleon from Semi-Inclusive Spin Asymmetries
We present a measurement of semi-inclusive spin asymmetries for positively
and negatively charged hadrons from deep inelastic scattering of polarised
muons on polarised protons and deuterons in the range 1
GeV. Compared to our previous publication on this subject, with the new
data the statistical errors have been reduced by nearly a factor of two.
From these asymmetries and our inclusive spin asymmetries we determine the
polarised quark distributions of valence quarks and non-strange sea quarks at
=10 GeV. The polarised valence quark distribution, , is positive and the polarisation increases with . The polarised
valence quark distribution, , is negative and the non-strange
sea distribution, , is consistent with zero over the measured
range of . We find for the first moments , and
, where we assumed
. We also determine for the first time the
second moments of the valence distributions .Comment: 17 page
- …